Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
04/2002
04/04/2002US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity
04/04/2002US20020039767 Batch processing using nucleophilic compound
04/04/2002CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai
04/03/2002EP1193265A2 A process for the preparation of 4-[2-(aryl or heterocyclo)-1H-imidazol-1-yl]benzenesulfonamides
04/03/2002EP1193258A1 Process for the preparation of imidazole derivatives
04/03/2002EP1193254A1 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method of using the same
04/03/2002EP1192145A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
04/03/2002EP1192129A2 Pharmaceutical compounds
04/03/2002CN1082050C Azole cojpounds endowed with antimycotic activity for human and veterinary use
04/02/2002US6365752 Process for preparing 1-substituted 5-hydroxy-imidazoline-2,4-diones and 1-substituted 5-alkoxy-imidazoline-2,4-diones
04/02/2002US6365746 Stable and water soluble bis Au(I) complexes and their synthesis
04/02/2002US6365743 Process for the preparation of enantiomerically pure imidazolyl compounds
04/02/2002US6365616 Transplant rejection
04/02/2002US6365590 Compounds, compositions and methods for treating erectile dysfunction
04/02/2002US6365301 Delocalized nitrogen, oxygen, sulfur or phoshorous onium cation; bis-fluorosulfonimidide anion or bis-difluorophos-phonylamidide anion
04/02/2002US6365068 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
03/2002
03/28/2002WO2002024658A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
03/28/2002WO2002024636A2 N-acylsulfonamide apoptosis promoters
03/28/2002WO2002024635A2 Aminoalcohol derivatives
03/28/2002WO2002024632A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
03/28/2002WO2001081315A3 Amino-imidazole derivatives for treating cancer
03/28/2002WO2001064631A3 Derives de polyfluoroalkylimidazole et leur utilisation en tant qu'antagonistes des recepteur muscariniques m3 et serotoniques 5-ht4
03/28/2002US20020038061 Synthesis of fluorocarbon compounds
03/28/2002US20020038059 Purification of alkenyl compounds
03/28/2002US20020038048 Catalytic asymmetric desymmetrization of meso compounds
03/28/2002US20020038035 1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders
03/28/2002US20020038034 Intermediates for the preparation of 2-imidazolin-5-ones
03/28/2002US20020037905 N-phenyl-N'-(2-carboxyphenyl) urea, for example; chloride channel blockers; such as for treating bone metabolic disorders
03/28/2002US20020037896 Bicyclic compounds
03/28/2002US20020037888 4-imidazol-1-ylmethyl-2-(2-(2-oxo-piperidin-1-yl)-phenoxy) -benzonitrile for example; farnesyl-protein transferase inhibitors; treating cancer, benign proliferative disorder, hepatitis virus, restenosis, and polycystic kidney disease
03/28/2002CA2421823A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
03/27/2002EP1191611A2 Piezoelectric element and process for production thereof
03/27/2002EP1191106A1 Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren
03/27/2002EP1189929A2 Factor viia inhibitors
03/27/2002EP1189889A1 Compositions and methods for inhibiting cell death
03/27/2002EP1189879A1 INHIBITORS OF FACTOR Xa
03/27/2002EP1189873A1 Excitatory amino acid receptor modulators
03/27/2002EP1189862A1 Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates
03/27/2002EP0773946B1 Imidazopyridine-azolidinones
03/27/2002CN1342140A 硫代酰胺衍生物 Thioamide derivatives
03/27/2002CN1341593A Proteinase inhibitor
03/27/2002CN1341592A Proteinase inhibitor
03/27/2002CN1341590A Proteinase inhibitor
03/27/2002CN1081637C Radiosensitizing diamines and their pharmaceutical preparations
03/27/2002CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists
03/27/2002CA2321348A1 Aromatic derivatives with hiv integrase inhibitory properties
03/26/2002US6362373 Chiral amino alcohols and process for preparation of same
03/26/2002US6362343 Reacting water miscible olefin in water with acylurea imidazole compound
03/26/2002US6362212 Oxime derivative and bactericide containing the same as active ingredient
03/26/2002US6362211 Polycyclic indanylimidazoles with alpha2 adrenergic activity
03/26/2002US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use
03/26/2002US6362208 Anilide compounds and drugs containing the same
03/26/2002CA2089954C 4-amino-2-ureidopyrimidine-5-carboxamides, a process for the preparation thereof, pharmaceuticals containing these compounds, and the use thereof
03/21/2002WO2002022626A1 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
03/21/2002WO2002022584A1 Thrombin inhibitors
03/21/2002WO2002022577A2 Hydroxamate derivatives useful as deacetylase inhibitors
03/21/2002WO2002022572A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
03/21/2002WO2002022556A1 Novel amide derivatives and medicinal use thereof ugs
03/21/2002WO2002022553A2 Non-natural basic amino acids, their preparation and use
03/21/2002WO2002022550A2 Chiral amino alcohols and process for preparation of same
03/21/2002WO2002000659A3 Methods of synthesis for 9-substituted hypoxanthine derivatives
03/21/2002WO2001072689A3 Method for separating a basic amino acid from fermentation broth
03/21/2002WO2001052656A3 1,3-dibromo-5,5-dimethylhydantoin of enhanced properties
03/21/2002WO2001034135A3 Oncolytic combinations for the treatment of cancer
03/21/2002US20020035290 Process for preparing malonate derivatives or beta -keto esters from epoxide derivatives
03/21/2002US20020035269 Method for separating a basic amino acid from fermentation broth
03/21/2002US20020035268 Decarboxylation of histamine
03/21/2002US20020035065 Selective MMP inhibitors having reduced side-effects
03/21/2002US20020035030 Contacting alpha-olefin with ransition metal complex of and Bronsted or Lewis acid to produce polyolefin
03/21/2002CA2459599A1 Non-natural basic amino acids, their preparation and use
03/21/2002CA2422055A1 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
03/21/2002CA2357469A1 Process for producing non-proteinogenic l-amino acids by fermentation
03/20/2002EP1188745A1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
03/20/2002EP1188439A2 Cell differentiation induction with mevalonate and mevalonolactone derivatives
03/20/2002EP1187817A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
03/20/2002EP0944587B1 Metalloproteinase inhibitors
03/19/2002US6359145 Imidazole compounds
03/19/2002US6359134 Sulfonamide derivatives, their production and use
03/19/2002US6359061 Combinatorial libraries are useful for screening in biologcal assays in order to identify pharmaceutically useful compounds
03/19/2002US6358987 For therapy and prophylaxis of rheumatoid arthritis, osteoarthritis, osteopenias such as osteoporosis, periodontitis, gingivitis, corneal epidermal or gastric ulceration, and tumour metastasis, invasion and growth
03/19/2002US6358983 Heterocyclically substituted α-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists
03/19/2002US6358961 Farnesyltransferase inhibiting quinazolinones
03/19/2002US6358956 Inhibitors of prenyl-protein transferase
03/19/2002US6358955 Schizophrenia, psychological disorders, parkinson*s disease; antidepressants
03/19/2002US6358928 Treating respiratory system, rheumatic and genetic disorders
03/19/2002US6358922 Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
03/19/2002US6358885 Preemergent or postemergent herbicides or plant growth regulants
03/19/2002US6358634 Nitrogen-containing heterocyclic compound, organic light-emitting device material and organic light-emitting device
03/14/2002WO2002020500A2 Materials and methods to potentiate cancer treatment
03/14/2002WO2002020495A2 Inhibitors of glycogen synthase kinase 3
03/14/2002WO2002020493A2 A traceless solid-phase synthesis of 2-imidazolones
03/14/2002WO2002020474A2 Resorcinol derivatives
03/14/2002WO2001070757A3 Thioketals and thioethers for inhibiting the expression of vcam-1
03/14/2002WO2001064671A3 Haloimidazole derivatives and their use as muscarinic m3 and serotoninergic 5-ht4 receptors
03/14/2002WO2001058852A3 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils
03/14/2002WO2001051486A3 Process and intermediates for the preparation of imidazopyridines
03/14/2002WO2001030327A3 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of ischaemic conditions
03/14/2002US20020032227 Oxime derivative and bactericide containing the same as active ingredient
03/14/2002US20020032211 Novel dihydronaphthalene compounds and processes of producing the same
03/14/2002US20020032210 Chloride channel blockers; useful in the treatment of sickle cell anaemia, brain edema following iscaemia or tumors, diarrhea, hypertension, bone metabolic disorders, osteoclast associated disoders; substituted biphenyl containing nitrogen